You are here:
Statistics measuring the GAVI Alliance's impact on global immunisation
Every year, academics, journalists, teachers and students ask for statistics detailing GAVI's results since the Alliance was established in 2000. Sourcing the GAVI Secretariat and members of the Alliance, including WHO, UNICEF and civil society organisations, these key facts and figures list GAVI's achievements to date as well as demonstrating the Alliance's catalytic role within global immunisation.
73 countries
In 2011, 73 countries are eligible for GAVI support for new and underused vaccines.
Source: Source: GAVI Alliance data 2011
230 million
If fully funded, GAVI will roll out the five-in-one pentavalent vaccine to 230 million additional children through to 2015.
Source: GAVI business plan 2010
MDG4
GAVI support for increased immunisation will make significant contributions to achieving Millennium Development Goal 4 to reduce child mortality.
82%
DTP3 coverage – three doses of diphtheria, tetanus and pertussis – in low-income countries has increased from 66% in 2000 to 82% in 2011 – its highest level ever.
Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, November 2011
74%
Hepatitis B vaccine coverage has risen to 74% in low-income countries compared with 17% in 2000.
267 million
Since its launch in 2000, GAVI support has resulted in the immunisation of 267 million children with the hepatitis B vaccine.
Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, November 2010
US$ 750 million
The Bill & Melinda Gates Foundation gave GAVI a start-up grant of US$ 750 million in 1999.
Source: GAVI Alliance data 2010
36%
Pneumonia and diarrhoea together account for 36% of child deaths in low-income countries.
Source: WHO, World Health Statistics 2010
77 countries
77 GAVI-eligible countries have been approved for GAVI support for at least one vaccine.
Source: GAVI Alliance data, 2010
More than 50 countries
In 2010, more than 50 countries were co-financing new and underused vaccines.
US$ 7.2 billion
GAVI has committed US$ 7.2 billion in programme support to low-income countries until 2016.
Source: GAVI Alliance data November 2011
1.9 million
Since 2007, GAVI support has resulted in the immunisation of 1.9 million children with the rotavirus vaccine.
3.6 million
Since 2010, GAVI support has resulted in the immunisation of 3.6 million children with the pneumococcal vaccine.
124 million
Since its launch in 2000, GAVI support has resulted in the immunisation of 124 million children with the Haemophilus influenzae type b vaccine.
860,000
GAVI’s support for measles vaccine has averted 860,000 future deaths.
697,000
GAVI’s support for Haemophilus influenzae type b vaccine has averted 697,000 future deaths.
140,000
GAVI’s support for yellow fever vaccine has averted 140,000 future deaths.
474,000
GAVI’s support for pentavalent vaccine has averted 474,000 future deaths.
3.9 million
GAVI’s support for vaccines, including pneumococcal disease and rotavirus, through to 2015, could avert an additional 3.9 million future deaths.
243 million
GAVI support will result in the immunisation of 243 million additional children through to 2015.
90 million
GAVI support will result in the immunisation of 90 million additional children against pneumococcal disease (the leading cause of pneumonia) from 2011 to 2015.
50 million
GAVI support will result in the immunisation of 50 million additional children with rotavirus vaccine, the leading cause of diarrhoea, through to 2015.
326 million
Since its launch in 2000, GAVI support has contributed to the immunisation of an additional 326 million children in the poorest countries.
US$ 21 million
GAVI is investing more than US$ 21 million in civil society organisations in developing countries through to 2015.
Source: GAVI Alliance data 2011
20 seconds
One child dies from a vaccine-preventable disease every 20 seconds.
Source: WHO
1.7 million
1.7 million children die from vaccine-preventable diseases every year.
43 %
Forty-three percent of GAVI vaccines are produced by pharmaceutical companies based in emerging markets.
Source: GAVI Alliance data 2008
19 million
Over 19 million children, aged under five, remain unimmunised in the world.
Source: WHO/UNICEF coverage estimates 1980-2009, revision July 2011
7 million
Providing pneumococcal vaccines in 40 low-income countries will avert up to seven million future deaths by 2030.
GAVI’s support for hepatitis B vaccine has averted 3,896,000 future deaths from 2000 to 2011
5.5 million
GAVI support to countries has contributed to averting more than five and a half million future deaths.
08 May 2012
'One in six cancers worldwide are caused by infection'
BBC News
02 May 2012
GAVI man's mission to immunize every kid on earth
Reuters
27 April 2012
Ghana pioneers new child vaccines
BBC
17 April 2012
Gates Foundation, Brazilian Ministry of Health to Partner on Global Health Initiative
Philanthropy News Digest
US, Haiti kick off vaccination campaigns
Washington Post
31 March 2012
Integrating vaccines with other strategies is best formula-- Seth Berkley
Seminar Magazine
27 March 2012
Sport Relief videos raise awareness on immunisation
Sport Relief
23 March 2012
Bill Gates: 'We could save three million lives over the next decade'
The Guardian
Andrew Mitchell interview: 'this is the most interesting job I've had in politics'
19 March 2012
UK budget must stick to aid pledge to make real impact on lives of poorest
modal window here
